Mechanistic comparison of Gemfibrozil and Secologanin Tryptamine Alkaloids Compounds formed by condensation of secologanin with tryptamine resulting in based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
8
Shared Targets
20%
Jaccard Similarity
15%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Gemfibrozil and Secologanin share 8 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.200 means 20% of the combined target set is bound by both compounds. The IDF-weighted score of 0.148 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Gemfibrozil and Secologanin have in common?
Gemfibrozil and Secologanin share 8 molecular targets with a Jaccard similarity of 20%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Gemfibrozil and Secologanin be combined?
Gemfibrozil and Secologanin share 8 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Gemfibrozil or Secologanin?
Both Gemfibrozil and Secologanin have substantial PubMed research. View their individual profiles for full evidence scores.